ANITA DESWAL to Drug Administration Schedule
This is a "connection" page, showing publications ANITA DESWAL has written about Drug Administration Schedule.
Connection Strength
0.259
-
Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure. Cardiol Clin. 2008 Feb; 26(1):1-14, v.
Score: 0.061
-
The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. J Am Coll Cardiol. 2007 Jul 03; 50(1):32-6.
Score: 0.058
-
Role and optimal dosing of angiotensin-converting enzyme inhibitor therapy. Heart Fail Clin. 2005 Apr; 1(1):25-37.
Score: 0.049
-
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29; 99(25):3224-6.
Score: 0.033
-
Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J. 2012 Nov; 164(5):763-770.e3.
Score: 0.021
-
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011 Mar 03; 364(9):797-805.
Score: 0.019
-
Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure. Vasc Health Risk Manag. 2010 Aug 09; 6:449-55.
Score: 0.018